Clinical development and manufacturing

Processes are developed so we can manufacture clinical supplies of the
highly complex biologic drugs created in Israel and Australia.
We also carry out advanced preclinical and clinical testing to ensure
the safety and effectiveness of the new drug.

Testing

Innovative medicines are tested in rigorous clinical trials.

Read more: Discover why diversity in clinical trials is so important

Biosimilar drug development & pre-clinical testing

We begin development of our complex biosimilars,
highly similar copies of existing biologic drugs that no longer have market exclusivity.
We also test the safety and efficacy of our biologics and biosimilars.

Find out more: Go behind the scenes at our laboratory in Netanya
with Teva’s Biologics VP Nir Shapir

Biologics manufacturing technology and outsourcing

Here we make our biopharma products,
manufacturing drug products in Kfar Saba and drug substances in Ulm.

Commercial manufacturing

In Ulm we also manufacture biologic and biosimilar drug
substance for commercial manufacturing of drug products.

More info: Read about Teva’s one billion
investment in the state-of-the-art Ulm facility

Commercial manufacturing

Our plant focuses on the manufacture of biologic treatments
for commercial sale, including oncology drugs.

More info: See the manufacturing process in action in Vilnius

Patient material testing

Patient tests analyze how the biologic drugs behave in the human body.

More info: Discover how Teva’s investment in Debrecen
will double its testing capacity

Biologic drug discovery

Our scientists identify the ‘needle in a haystack’ candidates for biologic drugs.

Read more: Treating the untreatable: what are biologics? (tevapharm.com)